Article Details

Checkpoint Therapeutics, Inc. SEC 10-K Report - TradingView

Retrieved on: 2025-03-28 20:33:45

Tags for this article:

Click the tags to see associated articles and topics

Checkpoint Therapeutics, Inc. SEC 10-K Report - TradingView. View article details on hiswai:

Excerpt

Product Development: The company is developing several other product candidates, including CK-302 (an anti-GITR monoclonal antibody), olafertinib ...

Article found on: www.tradingview.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo